According to COVID19 Vaccine rollout tracking, Sri Lanka reaches 6 million milestone for Covid-19 vaccination drive. Over 6 million (6,138,757) first doses of the coronavirus vaccines have been administered in Sri Lanka. Over 51% of the total population above age 30 in Sri Lanka have been administered with at least the first dose of a COVID-19 vaccine, according to data released. As of now nearly 15% of the country’s population above the age 30 has received the 2nd dose of the COVID-19 vaccine.
Sri Lanka’s COVID19 Vaccine Rollout Tracking.
Sri Lanka’s COVID19 Vaccine Rollout Tracking.
India – AstraZeneca – 925,242 (1st jab) / 385,885 (2nd)
Russia – SputnikV – 159,081 (1st jab) / 14,464 (2nd)
China – Sinopharm – 4,748,225 (1st jab) / 1,313,337 (2nd)
US – PFizer – 67,826 (1st jab)
US – Moderna – (238,383)
According to the Government Information Department data, Sri Lanka reached 1 million milestone for Covid-19 vaccinations program on May 12, reached 2 million milestone on June 8, reached 3 million milestone on July 5th, reached 4 million milestone on July 12th, reached 5 million milestone on July 15th and reached 6 million milestone on July 20. More than 6 million Sri Lankans had received their first dose of a COVID-19 vaccine as at July 20th. The highest number of vaccines per day of 384,763 administered on July 14.
Sri Lanka President Gotabaya Rajapaksa has put forward a comprehensive mechanism to vaccinate a majority of the population against COVID-19 virus before September this year. President has advised the health officials to prioritize people over the age of 60, pregnant women and public sector employees during vaccination rollout. President Gotabaya Rajapaksa has instructed the health officials to vaccinate all those over the age of 30 in the Western Province before July 31.
January 29, The COVID-19 vaccination drive kicked off in Sri Lanka, a day after India’s gift of 5 lakh doses of Covishield vaccine reached the island nation. Sri Lanka is one of the leading developing countries in the world in implementing the vaccination Programme against COVID-19.
